Stefan G. Koenig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Stefan G. Koenig has a total of 297 co-authors. Here are the top co-authors by number of shared publications:
- Lori Gonnet
University of Birmingham
8 shared publications - Tomislav Friščić
School of Chemistry University of Birmingham Edgbaston Birmingham UK
8 shared publications - Karthik Nagapudi
Small Molecule Pharmaceutical Sciences, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA
7 shared publications - Cameron B. Lennox
School of Chemistry, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
5 shared publications - Junho Kim
Department of Chemistry, Frick Laboratory, Princeton University, Princeton, New Jersey 08544, United States
5 shared publications Michael E. Kopach
Small Molecule Design and Development, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, United States
5 shared publications
Latest Publications
- Open Access
- 24 February 2026
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 28 (25) , 10434-10446
Establishing parameters for resonant acoustic mixing (RAM) chemistry using Buchwald–Hartwig amination as a model
Using Buchwald–Hartwig coupling as a model, this work uses reaction screening together with in situ monitoring to establish design parameters and explore safety in scaling of liquid-assisted RAM-based reactions. Laser beam image designed by Freepik.
- 24 February 2026
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 28 (25) , 10434-10446
Open AccessEstablishing parameters for resonant acoustic mixing (RAM) chemistry using Buchwald–Hartwig amination as a model
Using Buchwald–Hartwig coupling as a model, this work uses reaction screening together with in situ monitoring to establish design parameters and explore safety in scaling of liquid-assisted RAM-based reactions. Laser beam image designed by Freepik.
- 3 September 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (37) , 34150-34168
Iron(III)-Mediated C–H Alkylation: One-Electron Differentiation Increases Activity and Chemoselectivity
The C-H functionalization of arenes mediated by well-defined bis(phosphine)-supported organometallic iron(III) complexes is described. One-electron oxidation of trans-(depe)2Fe(CH3)2 (depe = 1,2-bis(diethylphosphino)ethane) generated the corresponding isolable iron(III) dimethyl derivative that was unstable toward Fe-CH3 homolysis. Oxidation of the corresponding iron(II) bis(aryl) complex trans-(depe)2Fe(tolyl)2 resulted in rapid reductive elimination of the biaryl with formation of iron(I). These observations motivated the synthesis of the cationic iron(III) metallacycle derived from C-H activation of a neophyl ligand. This complex mediated the ortho-selective C(sp2)-H alkylation of a host of arene derivatives containing ketone, amide, pyridine, ester, and sulfoxide directing groups with greater selectivity and reactivity than the iron(II) counterpart. The effect of bis(phosphine) ligands was examined, where decreasing ligand lability correlated with a higher barrier. The experimental rate law, deuterium labeling studies, deuterium kinetic isotope effect experiments, and computational modeling support a reversible C-H activation step followed by rate-determining C(sp2)-C(sp3) reductive elimination. Using design principles to minimize undesired reactivity, the iron(III) cycloneophyl complex mediated more facile and chemoselective C-H functionalization with a broader directing group compatibility than the iron(II) analog, arising from a combination of increased ligand lability, less exergonic substrate coordination, an enhanced orbital hybridization effect in C-H activation, and more facile C-C reductive elimination.
- 3 September 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (37) , 34150-34168
Iron(III)-Mediated C–H Alkylation: One-Electron Differentiation Increases Activity and Chemoselectivity
The C-H functionalization of arenes mediated by well-defined bis(phosphine)-supported organometallic iron(III) complexes is described. One-electron oxidation of trans-(depe)2Fe(CH3)2 (depe = 1,2-bis(diethylphosphino)ethane) generated the corresponding isolable iron(III) dimethyl derivative that was unstable toward Fe-CH3 homolysis. Oxidation of the corresponding iron(II) bis(aryl) complex trans-(depe)2Fe(tolyl)2 resulted in rapid reductive elimination of the biaryl with formation of iron(I). These observations motivated the synthesis of the cationic iron(III) metallacycle derived from C-H activation of a neophyl ligand. This complex mediated the ortho-selective C(sp2)-H alkylation of a host of arene derivatives containing ketone, amide, pyridine, ester, and sulfoxide directing groups with greater selectivity and reactivity than the iron(II) counterpart. The effect of bis(phosphine) ligands was examined, where decreasing ligand lability correlated with a higher barrier. The experimental rate law, deuterium labeling studies, deuterium kinetic isotope effect experiments, and computational modeling support a reversible C-H activation step followed by rate-determining C(sp2)-C(sp3) reductive elimination. Using design principles to minimize undesired reactivity, the iron(III) cycloneophyl complex mediated more facile and chemoselective C-H functionalization with a broader directing group compatibility than the iron(II) analog, arising from a combination of increased ligand lability, less exergonic substrate coordination, an enhanced orbital hybridization effect in C-H activation, and more facile C-C reductive elimination.
- Open Access
- 27 June 2025
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 13 (27) , 10268-10284
Environmental Sustainability Strategy of Active Pharmaceutical Ingredient Manufacturing: A Perspective from the American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable
- 27 June 2025
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 13 (27) , 10268-10284
Open AccessEnvironmental Sustainability Strategy of Active Pharmaceutical Ingredient Manufacturing: A Perspective from the American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable
- 5 May 2025
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (5) , 1228-1236
Development of a Broadly Applicable Enzymatic Ligation Process for the Production of Single Guide RNAs
- 5 May 2025
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 29 (5) , 1228-1236
Development of a Broadly Applicable Enzymatic Ligation Process for the Production of Single Guide RNAs
- Open Access
- 15 December 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Rapid, Scalable Buchwald-Hartwig Amination by Resonant Acoustic Mixing (RAM): Establishing Parameters for RAM Reaction Design
We outline the systematic development of Resonant Acoustic Mixing (RAM) for rapid, scalable Buchwald-Hartwig amination in the absence of bulk solvent. While RAM is rapidly emerging as a scalable methodology for media-free mechanochemical synthesis, the design parameters for reaction control, optimization, and scale-up remain poorly understood. This study establishes the filling ratio (φ), acceleration, and amount of liquid additive (η) as three critical parameters that can be used to design scalable Buchwald-Hartwig coupling reactions under RAM conditions. Systematic investigation of several model reactions reveals a relationship between reaction conversion and φ, providing a simple means to maximize conversion. The simultaneous real-time in situ monitoring of a model reaction through infrared thermography, fingerprint Raman, as well as low-frequency Raman (THz-Raman) spectroscopy enabled correlation of the reaction progress with the evolution of temperature during RAM, and established the RAM acceleration as a parameter that can be used to tune the reaction kinetic behavior. At high accelerations the reactions can proceed under sigmoidal kinetics, enabling multi-gram syntheses within 5 minutes, while lower accelerations can be used to switch the reactions to a more linear kinetic profile, associated with longer reaction times and milder temperature profiles. Following the reaction progress in the THz-Raman region is a reaction monitoring strategy that enables the detection of crystalline and non-crystalline phases in the reaction, permitting the observation of a non-crystalline intermediate whose evolution and replacement with the crystalline product could be tracked through non-negative least-squares fitting algorithm of the real-time spectroscopic data. This study establishes key parameters for manipulating the course and stoichiometric selectivity of a metal-catalyzed reaction in RAM and illustrates the scalability to at least 100 mmol without any protocol changes, except the volume of the vessel.
- 15 December 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessRapid, Scalable Buchwald-Hartwig Amination by Resonant Acoustic Mixing (RAM): Establishing Parameters for RAM Reaction Design
We outline the systematic development of Resonant Acoustic Mixing (RAM) for rapid, scalable Buchwald-Hartwig amination in the absence of bulk solvent. While RAM is rapidly emerging as a scalable methodology for media-free mechanochemical synthesis, the design parameters for reaction control, optimization, and scale-up remain poorly understood. This study establishes the filling ratio (φ), acceleration, and amount of liquid additive (η) as three critical parameters that can be used to design scalable Buchwald-Hartwig coupling reactions under RAM conditions. Systematic investigation of several model reactions reveals a relationship between reaction conversion and φ, providing a simple means to maximize conversion. The simultaneous real-time in situ monitoring of a model reaction through infrared thermography, fingerprint Raman, as well as low-frequency Raman (THz-Raman) spectroscopy enabled correlation of the reaction progress with the evolution of temperature during RAM, and established the RAM acceleration as a parameter that can be used to tune the reaction kinetic behavior. At high accelerations the reactions can proceed under sigmoidal kinetics, enabling multi-gram syntheses within 5 minutes, while lower accelerations can be used to switch the reactions to a more linear kinetic profile, associated with longer reaction times and milder temperature profiles. Following the reaction progress in the THz-Raman region is a reaction monitoring strategy that enables the detection of crystalline and non-crystalline phases in the reaction, permitting the observation of a non-crystalline intermediate whose evolution and replacement with the crystalline product could be tracked through non-negative least-squares fitting algorithm of the real-time spectroscopic data. This study establishes key parameters for manipulating the course and stoichiometric selectivity of a metal-catalyzed reaction in RAM and illustrates the scalability to at least 100 mmol without any protocol changes, except the volume of the vessel.
- 25 October 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (44) , 30637-30652
Redox-Neutral, Iron-Mediated Directed C–H Activation: General Principles and Mechanistic Insights
Experimental and computational studies have been conducted and established the general principles for enabling redox-neutral C-H activation by iron(II) complexes. The idealized octahedral iron(II) dimethyl complex, (depe)2Fe(CH3)2 (depe = 1,2-bis(diethylphosphino)ethane) promoted the directed, regioselective ortho C(sp2)-H methylation of pivalophenone. The rate of the iron(II)-mediated C(sp2)-H functionalization depended on the lability of L-type phosphine ligands, the spin state of the iron center, and the size of the X-type ligands (halide, hydrocarbyl) in P4FeIIX2 complexes. The C(sp2)-H alkylation reaction proved general among multiple substrates with directing groups including carbonyl, imines and pyridines. Among these, ketones and aldehydes were identified as optimal and were compatible with various steric environments and presence of acidic α-hydrogens. With stronger nitrogen donors, higher barriers for product-forming reductive elimination were observed. The effect of orbital hybridization on the chemoselectivity of C-H activation through a σ-CAM pathway by dn>0 transition metals was also established by studying the stoichiometric reactivity of the differentially substituted (depe)2Fe(Me)R complexes (R = alkyl, aryl), where the Fe-R bond with greater s-character preferentially promoted selective C-H activation. Deuterium labeling and kinetic studies, coupled with computational analysis, supported a pathway involving phosphine dissociation and rate-determining C-H bond activation, leading to the observed products.
- 25 October 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (44) , 30637-30652
Redox-Neutral, Iron-Mediated Directed C–H Activation: General Principles and Mechanistic Insights
Experimental and computational studies have been conducted and established the general principles for enabling redox-neutral C-H activation by iron(II) complexes. The idealized octahedral iron(II) dimethyl complex, (depe)2Fe(CH3)2 (depe = 1,2-bis(diethylphosphino)ethane) promoted the directed, regioselective ortho C(sp2)-H methylation of pivalophenone. The rate of the iron(II)-mediated C(sp2)-H functionalization depended on the lability of L-type phosphine ligands, the spin state of the iron center, and the size of the X-type ligands (halide, hydrocarbyl) in P4FeIIX2 complexes. The C(sp2)-H alkylation reaction proved general among multiple substrates with directing groups including carbonyl, imines and pyridines. Among these, ketones and aldehydes were identified as optimal and were compatible with various steric environments and presence of acidic α-hydrogens. With stronger nitrogen donors, higher barriers for product-forming reductive elimination were observed. The effect of orbital hybridization on the chemoselectivity of C-H activation through a σ-CAM pathway by dn>0 transition metals was also established by studying the stoichiometric reactivity of the differentially substituted (depe)2Fe(Me)R complexes (R = alkyl, aryl), where the Fe-R bond with greater s-character preferentially promoted selective C-H activation. Deuterium labeling and kinetic studies, coupled with computational analysis, supported a pathway involving phosphine dissociation and rate-determining C-H bond activation, leading to the observed products.
- Open Access
- 28 March 2024
- Published by Royal Society of Chemistry (RSC) in RSC Mechanochemistry
- Vol. 1 (3) , 244-249
Synthesis of short DNA and RNA fragments by resonant acoustic mixing (RAM)
We demonstrate the first use of Resonant Acoustic Mixing (RAM) without bulk solvent for the synthesis of short oligonucleotide fragments.
- 28 March 2024
- Published by Royal Society of Chemistry (RSC) in RSC Mechanochemistry
- Vol. 1 (3) , 244-249
Open AccessSynthesis of short DNA and RNA fragments by resonant acoustic mixing (RAM)
We demonstrate the first use of Resonant Acoustic Mixing (RAM) without bulk solvent for the synthesis of short oligonucleotide fragments.
- Top Cited PapersOpen Access
- 20 March 2024
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 89 (7) , 4261-4282
Process Mass Intensity (PMI): A Holistic Analysis of Current Peptide Manufacturing Processes Informs Sustainability in Peptide Synthesis
Small molecule therapeutics represent the majority of the FDA-approved drugs. Yet, many attractive targets are poorly tractable by small molecules, generating a need for new therapeutic modalities. Due to their biocompatibility profile and structural versatility, peptide-based therapeutics are a possible solution. Additionally, in the past two decades, advances in peptide design, delivery, formulation, and devices have occurred, making therapeutic peptides an attractive modality. However, peptide manufacturing is often limited to solid-phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS), and to a lesser extent hybrid SPPS/LPPS, with SPPS emerging as a predominant platform technology for peptide synthesis. SPPS involves the use of excess solvents and reagents which negatively impact the environment, thus highlighting the need for newer technologies to reduce the environmental footprint. Herein, fourteen American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable (ACS GCIPR) member companies with peptide-based therapeutics in their portfolio have compiled Process Mass Intensity (PMI) metrics to help inform the sustainability efforts in peptide synthesis. This includes PMI assessment on 40 synthetic peptide processes at various development stages in pharma, classified according to the development phase. This is the most comprehensive assessment of synthetic peptide environmental metrics to date. The synthetic peptide manufacturing process was divided into stages (synthesis, purification, isolation) to determine their respective PMI. On average, solid-phase peptide synthesis (SPPS) (PMI ≈ 13,000) does not compare favorably with other modalities such as small molecules (PMI median 168-308) and biopharmaceuticals (PMI ≈ 8300). Thus, the high PMI for peptide synthesis warrants more environmentally friendly processes in peptide manufacturing.
- 20 March 2024
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 89 (7) , 4261-4282
Top Cited PapersOpen AccessProcess Mass Intensity (PMI): A Holistic Analysis of Current Peptide Manufacturing Processes Informs Sustainability in Peptide Synthesis
Small molecule therapeutics represent the majority of the FDA-approved drugs. Yet, many attractive targets are poorly tractable by small molecules, generating a need for new therapeutic modalities. Due to their biocompatibility profile and structural versatility, peptide-based therapeutics are a possible solution. Additionally, in the past two decades, advances in peptide design, delivery, formulation, and devices have occurred, making therapeutic peptides an attractive modality. However, peptide manufacturing is often limited to solid-phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS), and to a lesser extent hybrid SPPS/LPPS, with SPPS emerging as a predominant platform technology for peptide synthesis. SPPS involves the use of excess solvents and reagents which negatively impact the environment, thus highlighting the need for newer technologies to reduce the environmental footprint. Herein, fourteen American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable (ACS GCIPR) member companies with peptide-based therapeutics in their portfolio have compiled Process Mass Intensity (PMI) metrics to help inform the sustainability efforts in peptide synthesis. This includes PMI assessment on 40 synthetic peptide processes at various development stages in pharma, classified according to the development phase. This is the most comprehensive assessment of synthetic peptide environmental metrics to date. The synthetic peptide manufacturing process was divided into stages (synthesis, purification, isolation) to determine their respective PMI. On average, solid-phase peptide synthesis (SPPS) (PMI ≈ 13,000) does not compare favorably with other modalities such as small molecules (PMI median 168-308) and biopharmaceuticals (PMI ≈ 8300). Thus, the high PMI for peptide synthesis warrants more environmentally friendly processes in peptide manufacturing.
- 5 January 2024
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (2) , 1262-1313
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models
The identification of VHL-binding proteolysis targeting chimeras (PROTACs) that potently degrade the BRM protein (also known as SMARCA2) in SW1573 cell-based experiments is described. These molecules exhibit between 10- and 100-fold degradation selectivity for BRM over the closely related paralog protein BRG1 (SMARCA4). They also selectively impair the proliferation of the H1944 "BRG1-mutant" NSCLC cell line, which lacks functional BRG1 protein and is thus highly dependent on BRM for growth, relative to the wild-type Calu6 line. In vivo experiments performed with a subset of compounds identified PROTACs that potently and selectively degraded BRM in the Calu6 and/or the HCC2302 BRG1 mutant NSCLC xenograft models and also afforded antitumor efficacy in the latter system. Subsequent PK/PD analysis established a need to achieve strong BRM degradation (>95%) in order to trigger meaningful antitumor activity in vivo. Intratumor quantitation of mRNA associated with two genes whose transcription was controlled by BRM (PLAU and KRT80) also supported this conclusion.
- 5 January 2024
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (2) , 1262-1313
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models
The identification of VHL-binding proteolysis targeting chimeras (PROTACs) that potently degrade the BRM protein (also known as SMARCA2) in SW1573 cell-based experiments is described. These molecules exhibit between 10- and 100-fold degradation selectivity for BRM over the closely related paralog protein BRG1 (SMARCA4). They also selectively impair the proliferation of the H1944 "BRG1-mutant" NSCLC cell line, which lacks functional BRG1 protein and is thus highly dependent on BRM for growth, relative to the wild-type Calu6 line. In vivo experiments performed with a subset of compounds identified PROTACs that potently and selectively degraded BRM in the Calu6 and/or the HCC2302 BRG1 mutant NSCLC xenograft models and also afforded antitumor efficacy in the latter system. Subsequent PK/PD analysis established a need to achieve strong BRM degradation (>95%) in order to trigger meaningful antitumor activity in vivo. Intratumor quantitation of mRNA associated with two genes whose transcription was controlled by BRM (PLAU and KRT80) also supported this conclusion.